Daniel Vilarim Araújo

First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)

Anna Spreafico, Alya Heirali, Daniel Vilarim Araújo et al. · Annals of Oncology · 2023 · 90 citations · Full text

MRP1 expression in CTCs confers resistance to irinotecan‐based chemotherapy in metastatic colorectal cancer

Emne Ali Abdallah, Marcello Ferretti Fanelli, Virgílio Souza e Silva et al. · International Journal of Cancer · 2016 · 57 citations

Pathology, Cancer Biology, Tumor Biology +17

Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5‐fluorouracil resistance in metastatic colorectal cancer patients

Emne Ali Abdallah, Marcello Ferretti Fanelli, Marcilei Eliza Cavicchioli Buim et al. · International Journal of Cancer · 2015 · 54 citations · Full text

New Tool, Immunology, Pathology +17

Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study

Marc Oliva, Douglas B. Chepeha, Daniel Vilarim Araújo et al. · Journal for ImmunoTherapy of Cancer · 2021 · 51 citations · Full text

First-in-class microbial ecosystem therapeutics 4 (MET4) in metastatic solid cancer patients treated with immunotherapy: MET4-IO.

Daniel Vilarim Araújo, M. Oliva Bernal, Tira J. Tan et al. · Journal of Clinical Oncology · 2020 · 28 citations